Genetically modified T-lymphocytes for arthritis therapy
After the introduction of genetically modified lymphocytes to mice with arthritis in the foci of rheumatoid inflammation, a decrease in the number of T-helpers and destructive processes of bone tissue, i.e., a decrease in the autoimmune reaction, was observed.
03.12.2009